Financial statements Bio-Tech Consulting
Balance sheet data of BIO-TECH CONSULTING
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 4 891 893,55 | 3 378 973,00 | 3 335 242,11 | 3 206 026,47 | 2 537 955,81 | 2 888 036,08 |
A. Fixed assets | 3 633 015,05 | 2 558 731,93 | 2 363 700,38 | 2 289 250,44 | 1 454 297,57 | 1 420 876,01 |
B. Current assets | 1 258 878,50 | 820 241,07 | 971 541,73 | 916 776,03 | 1 083 658,24 | 1 467 160,07 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 4 891 893,55 | 3 378 973,00 | 3 335 242,11 | 3 206 026,47 | 2 537 955,81 | 2 888 036,08 |
A. Equity | 4 178 957,32 | 2 889 840,87 | 2 728 088,21 | 2 610 418,31 | 2 366 564,35 | 2 175 420,46 |
B. Liabilities and provisions for liabilities | 712 936,23 | 489 132,13 | 607 153,90 | 595 608,16 | 171 391,46 | 712 615,62 |
I. Long-term liabilities | 0,00 | 0,00 | 68 890,00 | 42 226,00 | 0,00 | 0,00 |
II. Short-term liabilities | 459 070,29 | 489 132,13 | 538 263,90 | 553 382,16 | 171 391,46 | 712 615,62 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.